Changgong Zhang

机构：Xiamen Tobacco Industry (China) · ORCID：0000-0002-0971-5585

发表论文 147 篇 · 总被引 1456 次 · h-index 22

代表论文

• Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018) (2022 · Cancer Pathogenesis and Therapy · 被引 25)
• Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein (2023 · International Journal of Biological Macromolecules · 被引 9)
• Efficacy and safety of PD‐1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients (2023 · European Journal Of Haematology · 被引 9)
• An Image Fusion Method Based on Special Residual Network and Efficient Channel Attention (2022 · Electronics · 被引 9)
• Development of a test strip for rapid detection of Gymnodinium catenatum (2022 · Environmental Monitoring and Assessment · 被引 7)
• High-affinity VNARs targeting human hemoglobin: Screening, stability and binding analysis (2025 · International Journal of Biological Macromolecules · 被引 6)